Cui Yanyan, Yin Shan, Qin Xuejiao, Jiao Wanzhen, Ren Anqi, Wang Fei, Zhao Bojun
Shandong University of Traditional Chinese Medicine, Jinan, China.
The Second Hospital of Shandong University, Jinan, China.
Front Med (Lausanne). 2022 Oct 18;9:975565. doi: 10.3389/fmed.2022.975565. eCollection 2022.
Intraocular malignant tumors including primary and metastatic tumors, are mainly found in Retina and uvea, and very few cases originate from the sclera and optic nerve. Intraocular tumors can endanger the patient's vision and even life, and proper treatment is vital. There have been several traditional treatments for intraocular tumors, such as radiotherapy, chemotherapy and surgery. In recent years, new methods have been developed in clinical applications including anti-VEGF and gene therapy. This paper aims to provide a timely review about recent progress in the treatment of intraocular malignant tumor.
眼内恶性肿瘤包括原发性和转移性肿瘤，主要发生于视网膜和葡萄膜，极少数病例起源于巩膜和视神经。眼内肿瘤可危及患者视力甚至生命，恰当的治疗至关重要。眼内肿瘤有多种传统治疗方法，如放疗、化疗和手术。近年来，临床应用中已开发出包括抗血管内皮生长因子（VEGF）和基因治疗在内的新方法。本文旨在及时综述眼内恶性肿瘤治疗的最新进展。
